ABC
La congiuntivite batterica
IRENE BERTI, CHIARA TREVISIOL, FEDERICO MARCHETTI
Clinica Pediatrica, IRCCS “Burlo Garofolo”, Università di Trieste
Febbraio 2003 - pagg. 116 -119
Parole chiave
Suggerite dall'AI
Classificazione MeSH
Bibliografia
1. Weiss A. Acute conjunctivitis in childhood.
Curr Probl Pediatr 1994;24:4-11.
2. Weiss A, Briner JH, Nazar-Stewart V. Acute conjunctivitis in childhood. J Pediatr 1993; 12:10-4.
3. Hammerschlag MR, Cummings C, Roblin PM, et al. Efficacy of neonatal ocular prophylaxis for the prevention of chlamydial and gonococcal conjunctivitis. N Engl J Med 1989; 320:769.
4. Leibowitz HM. The Red eye. N Engl J Med 2000;343:345-51.
5. Wald ER. Conjuntivitis in infants and children. Pediatr Infect Dis J 1997;16:S17-20.
6. Wishart PK, James C, Wishart MS, Darougar S. Prevalence of acute conjunctivitis caused by chlamydia, adenovirus and herpes simplex virus in an ophthalmic casualty department. Br J Ophthalmol 1984;68:653-5.
7. Bodor FF. Conjunctivitis-otitis media syndrome: more than meets the eye. Contemp Pediatr 1989;6:55-60.
8. Sheikh A, Hurwitz B, Cave J. Antibiotic versus placebo for acute bacterial conjunctivitis. The Cochrane Database Syst Rev 2000 (2):CD001211.
9. Lo Preti C. La congiuntivite ha bisogno sempre di una terapia empirica con antibiotico? Quaderni acp 2002;2:46-7.
10. Chung C, Cohen E. La congiuntivite batterica. Clinical Evidence (vol I - ed italiana): pag.317-21.
11. Gigliotti F, Hendley JO, Morgan J, et al. Efficacy of topical antibiotic therapy in acute conjunctivitis in children. J Pediatr 1984;104: 623-6.
12. Leibowitz HM. Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis. Am J Ophthalmol 1991;112:29S-33S.
13. Miller IM, Wittreich J, Vogel R, Cook TJ, for the Norfloxacin-Placebo Ocular Study Group. The safety and efficacy of topical norfloxacin compared with placebo in the treatment of acute bacterial conjunctivitis. Eur J Ophthalmol 1992;2:58-66.
14. Kettenmeyer A, Jauch A, Boscher M, et al. A double-blind double-dummy multicenter equivalence study comparing topical lomefloxacin 0.3% twice daily with norfloxacin 0.3% four times daily in the treatment of acute bacterial conjunctivitis. J Clin Res 1998;1:75- 86.
15. Agius-Fernandez A, Patterson A, Fsadni M, et al. Topical lomefloxacin versus topical chloramphenicol in the treatment of acute bacterial conjunctivitis. Clin Drug Invest 1998; 15:263-9.
16. Montero J, Cassado A, Perea E, et al. A double blind double dummy comparison of topical lomefloxacin 0.3% twice daily with topical gentamicin 0.3% four times daily in the treatment of acute bacterial conjunctivitis. J Clin Res 1998;1:29-39.
17. Adenis JP, Arrata M. Gastaud P, et al. Etude randomisée multicentrique avec acid fusidique gel ophtalmique et rifamycine collyre dans les conjonctivites aiguës. J Fr Ophtalmol 1989;12:317-22.
18. Huerva V, Ascaso FJ, Latre B, et al. Tolerancia y efficacia de la tobramicina topica vs cloramfenicol en el tratamiento de las conjunctivitis bacterians. Ciencia Pharmaceutica 1991;
19. Gallenga PE, Lobefalo L, Colangelo L, et al. Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: a multicenter double-blind phase III study. Ophthalmologica 1999;213:250- 7.
20. Gross RD, Hoffman RO, Lindsay RN. A comparison of ciprofloxacin and tobramycin in bacterial conjunctivitis in children. Clin Pediatr 1997;36:435-44.
21. Lohr JA, Austin RD, Grossman M, Comparison of three topical antimicrobials for acute bacterial conjunctivitis. Pediatr Infect Dis J 1988,7:626-9.
22. Van Bijsterveld OP, el Batawi Y, Sobhi FS, et al. Fusidic acid in infections of the external eye. Infection 1987;15:16-9.
23. Tabbara KF, EI-Sheik HF, Monowarul Islam SM, Hammouda E. Treatment of acute bacterial conjuntivictis with topical lomefloxacin 0,3% compared to topical ofloxacin 0.3%. Eur J Ophthalmol 1999;9:269-75.
24. Papa V, Aragona P, Scuderi AC, et al. Treatment of acute bacterial conjunctivitis with topical netilmicin. Cornea 2002;21(1):43-7.
25. Smith A, Pennefather PM, Kaye SB, Hart CA. Fluoroquinolones: place in ocular therapy. Drugs 2001;61(6):747-61.
26. Ministero della Salute. Guida all’uso dei farmaci. Sulla base del British National Formulary. Giugno 2002.
27. Lancaste T, Swart AM, Hershel J. Risk of serious haematological toxicity with use of chloramphenicol eye drops in a British general practice database. BMJ 1998;316:667.
28. Wiholm BE, Kelly JP, Kaufman D, et al. Relation of aplastic anaemia to use of chloramphenicol eye drops in two international case-control studies. BMJ 1998;316 (7132): 666
29. Donna M, Walsh JB. Use of chloramphenicol as topical eye medication: time to cry halt? BMJ 1995;310:1217-8
30. Black SL, Hedrick J, Tyler R, et al. Increasing bacterial resistence in pediatric acute conjunctivitis (1997-1998). Antimicrob Agents Chemother 2000;44(6):1650-4.
31. Robert PY, Adenis JP. Comparative review of topical ophthalmic antibacterial preparations. Drugs 2001;61(2):175-85.
2. Weiss A, Briner JH, Nazar-Stewart V. Acute conjunctivitis in childhood. J Pediatr 1993; 12:10-4.
3. Hammerschlag MR, Cummings C, Roblin PM, et al. Efficacy of neonatal ocular prophylaxis for the prevention of chlamydial and gonococcal conjunctivitis. N Engl J Med 1989; 320:769.
4. Leibowitz HM. The Red eye. N Engl J Med 2000;343:345-51.
5. Wald ER. Conjuntivitis in infants and children. Pediatr Infect Dis J 1997;16:S17-20.
6. Wishart PK, James C, Wishart MS, Darougar S. Prevalence of acute conjunctivitis caused by chlamydia, adenovirus and herpes simplex virus in an ophthalmic casualty department. Br J Ophthalmol 1984;68:653-5.
7. Bodor FF. Conjunctivitis-otitis media syndrome: more than meets the eye. Contemp Pediatr 1989;6:55-60.
8. Sheikh A, Hurwitz B, Cave J. Antibiotic versus placebo for acute bacterial conjunctivitis. The Cochrane Database Syst Rev 2000 (2):CD001211.
9. Lo Preti C. La congiuntivite ha bisogno sempre di una terapia empirica con antibiotico? Quaderni acp 2002;2:46-7.
10. Chung C, Cohen E. La congiuntivite batterica. Clinical Evidence (vol I - ed italiana): pag.317-21.
11. Gigliotti F, Hendley JO, Morgan J, et al. Efficacy of topical antibiotic therapy in acute conjunctivitis in children. J Pediatr 1984;104: 623-6.
12. Leibowitz HM. Antibacterial effectiveness of ciprofloxacin 0.3% ophthalmic solution in the treatment of bacterial conjunctivitis. Am J Ophthalmol 1991;112:29S-33S.
13. Miller IM, Wittreich J, Vogel R, Cook TJ, for the Norfloxacin-Placebo Ocular Study Group. The safety and efficacy of topical norfloxacin compared with placebo in the treatment of acute bacterial conjunctivitis. Eur J Ophthalmol 1992;2:58-66.
14. Kettenmeyer A, Jauch A, Boscher M, et al. A double-blind double-dummy multicenter equivalence study comparing topical lomefloxacin 0.3% twice daily with norfloxacin 0.3% four times daily in the treatment of acute bacterial conjunctivitis. J Clin Res 1998;1:75- 86.
15. Agius-Fernandez A, Patterson A, Fsadni M, et al. Topical lomefloxacin versus topical chloramphenicol in the treatment of acute bacterial conjunctivitis. Clin Drug Invest 1998; 15:263-9.
16. Montero J, Cassado A, Perea E, et al. A double blind double dummy comparison of topical lomefloxacin 0.3% twice daily with topical gentamicin 0.3% four times daily in the treatment of acute bacterial conjunctivitis. J Clin Res 1998;1:29-39.
17. Adenis JP, Arrata M. Gastaud P, et al. Etude randomisée multicentrique avec acid fusidique gel ophtalmique et rifamycine collyre dans les conjonctivites aiguës. J Fr Ophtalmol 1989;12:317-22.
18. Huerva V, Ascaso FJ, Latre B, et al. Tolerancia y efficacia de la tobramicina topica vs cloramfenicol en el tratamiento de las conjunctivitis bacterians. Ciencia Pharmaceutica 1991;
19. Gallenga PE, Lobefalo L, Colangelo L, et al. Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: a multicenter double-blind phase III study. Ophthalmologica 1999;213:250- 7.
20. Gross RD, Hoffman RO, Lindsay RN. A comparison of ciprofloxacin and tobramycin in bacterial conjunctivitis in children. Clin Pediatr 1997;36:435-44.
21. Lohr JA, Austin RD, Grossman M, Comparison of three topical antimicrobials for acute bacterial conjunctivitis. Pediatr Infect Dis J 1988,7:626-9.
22. Van Bijsterveld OP, el Batawi Y, Sobhi FS, et al. Fusidic acid in infections of the external eye. Infection 1987;15:16-9.
23. Tabbara KF, EI-Sheik HF, Monowarul Islam SM, Hammouda E. Treatment of acute bacterial conjuntivictis with topical lomefloxacin 0,3% compared to topical ofloxacin 0.3%. Eur J Ophthalmol 1999;9:269-75.
24. Papa V, Aragona P, Scuderi AC, et al. Treatment of acute bacterial conjunctivitis with topical netilmicin. Cornea 2002;21(1):43-7.
25. Smith A, Pennefather PM, Kaye SB, Hart CA. Fluoroquinolones: place in ocular therapy. Drugs 2001;61(6):747-61.
26. Ministero della Salute. Guida all’uso dei farmaci. Sulla base del British National Formulary. Giugno 2002.
27. Lancaste T, Swart AM, Hershel J. Risk of serious haematological toxicity with use of chloramphenicol eye drops in a British general practice database. BMJ 1998;316:667.
28. Wiholm BE, Kelly JP, Kaufman D, et al. Relation of aplastic anaemia to use of chloramphenicol eye drops in two international case-control studies. BMJ 1998;316 (7132): 666
29. Donna M, Walsh JB. Use of chloramphenicol as topical eye medication: time to cry halt? BMJ 1995;310:1217-8
30. Black SL, Hedrick J, Tyler R, et al. Increasing bacterial resistence in pediatric acute conjunctivitis (1997-1998). Antimicrob Agents Chemother 2000;44(6):1650-4.
31. Robert PY, Adenis JP. Comparative review of topical ophthalmic antibacterial preparations. Drugs 2001;61(2):175-85.